| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996747 | Practical Radiation Oncology | 2015 | 6 Pages |
Abstract
Respiratory-gated VMAT has the potential to reduce the dose to normal lung when treating early-stage NSCLC with SBRT for tumor motion greater than 5 mm.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ilma BSc, Jeff Z. PhD, Michael BSc, Edward MD, Stewart PhD,